Anemia: all 1,768 studies
Page 13 of 18. Open to participants first (244), then studies with results posted, then the rest; newest registration first within each.
- Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic SyndromeCompletedNCT02462252Phase 2
- A Comparison Between Intravenous Iron Sucrose to Its Combination With Oral Iron Supplements for the Treatment of Postpartum AnemiaCompletedNCT02458625Not applicable
- Study of Anemia in Chronic Kidney Disease (CKD) Among High-Risk Hypertensive and Diabetic Patients in PakistanCompletedNCT02444845
- To Compare the Efficacy of I.V 200 mg Iron Sucrose and 500 mg Iron Sucrose to Treat Anemia in PregnancyWithdrawnNCT02441439Not applicable
- A Cohort Study of Conversion From Aranesp® to NESP® for the Treatment of Anemia in Dialysis PatientsCompletedNCT02439697Not applicable
- Impact of RUTF on Body Composition, Anemia and Zinc Status of PLWHACompletedNCT02433743Not applicable
- Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic AnemiaStatus unknownNCT02407470Phase 1/2
- Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With Chronic Kidney Diseases Not on DialysisStatus unknownNCT02403362Phase 2
- L-leucine in Diamond Blackfan Anemia PatientsStatus unknownNCT02386267Phase 2
- Incidence and Reasons for Preoperative Anemia in Elective Lower Joint ArthroplastyStatus unknownNCT02385409
- An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational StudyStatus unknownNCT02385383
- Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to AngiodysplasiasCompletedNCT02384122Phase 3
- Drug-drug Interaction Study of GSK1278863 With Pioglitazone, Rosuvastatin and Trimethoprim in Healthy Adult VolunteersCompletedNCT02371603Phase 1
- Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With ERSD Receiving Maintenance HemodialysisStatus unknownNCT02366325Phase 2
- Lucky Iron Fish Home Fortification of IronCompletedNCT02341586Not applicable
- Use of Cast Iron Pots to Improve Maternal AnemiaTerminatedNCT02341300Not applicable
- Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy VolunteersCompletedNCT02293148Phase 1
- Gastric Capsule Examination for Iron Deficiency AnaemiaCompletedNCT02282553Not applicable
- Optimal Anemia Treatment in End Stage Renal Disease (ERSD)Status unknownNCT02273570Not applicable
- Mesenchymal Stem Cells Co-transplantation in Alternative Donor Transplantation of Severe Aplastic Anemia.Status unknownNCT02247973Phase 2
- Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of AnaemiaStatus unknownNCT02243735Phase 4
- A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)TerminatedNCT02243124Phase 1
- Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)CompletedNCT02232906Phase 4
- An Exploratory Study to Evaluate FMX-8 to Treat Anemia in CKDTerminatedNCT02228655Early Phase 1
- Ascorbic Acid Administration in the Treatment of Anemia in Chronic Hemodialysed PatientsStatus unknownNCT02225886Phase 4
- Effect of Timing of Umbilical Cord Clamping on Anaemia at 8 and 12 Months and Later NeurodevelopmentCompletedNCT02222805Not applicable
- Cholecalciferol Supplementation for Anemia and Mineral and Bone Disorder in Hemodialysis PatientsCompletedNCT02214563Phase 4
- Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis PatientsCompletedNCT02198495Phase 4
- Foetal Exposure and Epidemiological Transition: Role of Anaemia in Early Life for Non-communicable Diseases LaterCompletedNCT02191683
- Study of Haemodialysis Patients Switching From Aranesp to BiosimilarCompletedNCT02191150
- Safety and Efficacy Study of a Food Supplement for Pregnant and Lactating WomenWithdrawnNCT02190565Not applicable
- Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on DialysisCompletedNCT02185911
- Effect of Vitamin E Supplementation on Hemoglobin Levels in Healthy AdultsCompletedNCT02181348Phase 1/2
- The Optimization of Bioavailability From Iron Supplements: Study 2CompletedNCT02177851Not applicable
- Iron Absorption From Rice Fortified With Ferric PyrophosphateCompletedNCT02176759Not applicable
- The Optimization of Bioavailability From Iron Supplements: Study 1CompletedNCT02175888Not applicable
- A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against PlaceboWithdrawnNCT02172001Phase 3
- Pharmacokinetics, Pharmacodynamics and Safety Study of Z-213 to Iron Deficiency AnemiaCompletedNCT02170311Phase 1
- Study of Beet Juice for Patients With Sickle Cell AnemiaWithdrawnNCT02162225Phase 2
- Biosimilar Retacrit® in the Treatment of Chemotherapy-induced Anaemia in Oncology and HaematologyCompletedNCT02158169
- Questionnaire to Assess Gastrointestinal Symptoms of Oral Iron.CompletedNCT02146053Early Phase 1
- Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and OncologyCompletedNCT02140736
- Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating AgentsCompletedNCT02136563
- The Purpose of the Study is to Examine Whether Iron Deficiency Anemia is Associated With Increased Production of Thrombin and Whether Correction of Anemia by Providing Iron Intravenously Causes a Significant Reduction in Production of Thrombin.CompletedNCT02129907
- Unrelated HSCT in Patients With Fanconi AnemiaWithdrawnNCT02127905Not applicable
- Iron and Prebiotics Fortification in Kenyan InfantsCompletedNCT02118402Not applicable
- Immunoglobulin Dosage and Administration Form in CIDP and MMNCompletedNCT02111590
- Parenteral Artesunate Compared to Quinine as a Cause of Late Anaemia in African Children With MalariaCompletedNCT02092766Phase 4
- Risk-based Therapy for Sickle Cell Anemia: A Feasibility StudyWithdrawnNCT02090296Phase 2
- Iron Supplementation Using Total Dose Infusion and Oral Routes for Treatment of Iron Deficiency Anemia in PregnancyCompletedNCT02086838Phase 4
- Distribution of Fortified Yoghurt in Senegal to Decrease Children's Anemia and Improve Milk SupplyCompletedNCT02079961Early Phase 1
- Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis PatientsCompletedNCT02079896Phase 1/2
- Comparison of Ferrous Sulfate, Polymaltose Complex and Iron-zinc in Iron Deficiency AnemiaCompletedNCT02076828Not applicable
- Safe and Efficacious Iron for Children in KenyaCompletedNCT02073149Phase 2/3
- Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934CompletedNCT02064426Phase 2
- Effect of AKB-6548 on Cardiac Repolarization Intervals in Healthy VolunteersCompletedNCT02062203Phase 1
- Intravenous Iron: Measuring Response in Anemic Surgical PatientsCompletedNCT02057471Phase 4
- Long-term Pre-dialysis Extension in Europe and Asia PacificCompletedNCT02055482Phase 2
- Pyruvate Kinase Deficiency Natural History StudyCompletedNCT02053480
- Comparison Among Erythropoietin Stimulating AgentsCompletedNCT02049346Phase 4
- An Observational Study of Patients' Perception of Treatment With Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease Not on Dialysis (PERCEPOLIS)CompletedNCT02042833
- Variability of Hemoglobin Levels After Kidney TransplantationCompletedNCT02041208
- Fermented Iron-rich Supplement in Reducing AnemiaStatus unknownNCT02037724Phase 2
- Let's be Well Red: Efficacy of Gudness Bars in Improving the Hemoglobin and Hematocrit Levels of Anemic SubjectsCompletedNCT02032615Not applicable
- The Immunomodulatory Effects of PhlebotomyStatus unknownNCT02031614Not applicable
- Impact of Preoperative Treatment of Anemia and Iron Deficiency in Cardiac Surgery on Outcome.CompletedNCT02031289Phase 4
- Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic AnaemiaStatus unknownNCT02028416Not applicable
- Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934CompletedNCT02021409Phase 2
- 15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)CompletedNCT02021370Phase 2
- Treatment of Iron Deficiency Anemia With PregnancyCompletedNCT02005588Early Phase 1
- Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic AnemiaStatus unknownNCT01997372Phase 4
- Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic AnemiaStatus unknownNCT01995331Phase 4
- Effects of Vitamin D Replacement on Hormones Regulating Iron Metabolism in Individuals With Chronic Kidney DiseaseCompletedNCT01988116Early Phase 1
- Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency AnemiaCompletedNCT01984554
- Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934CompletedNCT01975818Phase 2
- The Effect of Chronic Anemia on Safety Period of Tracheal Intubation in Gynecology PatientsCompletedNCT01968525Not applicable
- Analysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferon/Ribavirin Therapy in HIV-HCV Co-infected PatientsCompletedNCT01964742Not applicable
- ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-CompletedNCT01964196Phase 2
- Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis PatientsCompletedNCT01942460Phase 4
- Iron Replacement in Oesophagogastric NeoplasiaStatus unknownNCT01927328Phase 4
- Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle CrisisWithdrawnNCT01925001Phase 2
- Evaluate the Accuracy of the NBM200 for Noninvasive Hemoglobin Measurements on Obstetric/Gynecological PatientsStatus unknownNCT01917851
- Bone Marrow Transplant With Abatacept for Non-Malignant DiseasesCompletedNCT01917708Phase 1
- Comparing Intravenous and Oral Iron in Postoperative AnemiaCompletedNCT01913808Phase 4
- Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter StudyStatus unknownNCT01905787
- Time to Relapse of Iron Deficiency Anemia After Standard Treatment With a New Intravenous Iron (Monofer®)CompletedNCT01900197
- A Description of Bacteria in the Mouths of Patients With Severe Aplastic AnemiaCompletedNCT01900119
- A Non-Interventional Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease Not on DialysisNo longer availableNCT01892202
- Zambia Micronutrient Powder Trial Effectiveness StudyCompletedNCT01878734Not applicable
- A Phase 2A Trial of FMX-8 Treatment for Anemia in Patients With ESRD on Hemodialysis HDTerminatedNCT01873534Phase 2
- Iron Supplementation for Acute Anemia After Postbariatric AbdominoplastyCompletedNCT01857011Phase 3
- An Open-label Trial to Determine Increased Red Blood Cell Production in Subjects With Anemia of Chronic DiseaseStatus unknownNCT01846689Phase 3
- Randomised Study Comparing Different Dosages of Rabbit ATG in Patients With SAAStatus unknownNCT01844635Phase 3
- Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant RecipientsTerminatedNCT01817699Phase 4
- Effect of Iron-fortified TPN on Preterm Infants AnemiaStatus unknownNCT01813682Not applicable
- Apotransferrin in AtransferrinemiaActive, not recruitingNCT01797055Phase 2
- Clinical Tumor Anemia Registry (TAR)CompletedNCT01795690
- Vitamin B12 Supplementation During PregnancyCompletedNCT01795131Phase 2/3
- Using Stable Iron Isotopic Techniques and Serum Hepcidin Profiles to Optimize Iron SupplementationCompletedNCT01785407Not applicable
- Influence of Exercise on Anemia in MDS PatientsWithdrawnNCT01783249Phase 1/2